MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202611112867 A) filed by Misbah Fayaz; Bisma Majid; Majid Rashid; Mansoor Showkat; Anjali Verma; Tabish Jaan; R Rajavishwa; Saika Bashir; Mahandiya Iqbal; and Sajad Majeed Zargar on September 21, 2026, for A Buckwheat-Derived Endophytic Microbial Consortium Having Antifungal Activity And Vitamin B12 Biosynthesis Capability.
Inventors include Misbah Fayaz; Bisma Majid; Majid Rashid; Mansoor Showkat; Anjali Verma; Tabish Jaan; R Rajavishwa; Saika Bashir; Mahandiya Iqbal; and Sajad Majeed Zargar.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: The present invention relates to a buckwheat-derived microbial consortium comprising endophytic bacteria and fungi isolated from seeds of Fagopyrum spp. The consortium comprises selected bacterial endophytes belonging to genera including Pantoea, Bacillus, Macrococcus, Calidifontibacillus and Staphylococcus, and selected fungal endophytes including Fusarium, Cladosporium, Alternaria, Allophoma and Bjerkandera. The microorganisms are isolated from surface-sterilised buckwheat seeds and molecularly characterised using 16S rRNA and ITS sequencing. Selected bacterial members exhibit antagonistic activity against phytopathogenic microorganisms including Fusarium oxysporum, Venturia inaequalis and Alternaria alternata. Selected bacterial members further exhibit Vitamin B12 biosynthesis capability determined by quantitative analytical analysis. The consortium may be formulated as a liquid or solid agricultural bioinoculant using an agriculturally acceptable carrier and applied to seeds, soil and/or plant surfaces. The invention provides a dual-purpose microbial platform for biological crop protection and nutritional enhancement of plants and is useful in sustainable agricultural applications.
Disclaimer: Curated by HT Syndication.
